Prognostic value of NT-proBNP in chronic pulmonary disease exacerbation;Valor pronóstico del NT-proBNP en pacientes con enfermedad pulmonar crónica reagudizada

Medicina Clinica

Volumn 135, Issue 10, 2010, Pages 441-446

  Sánchez Marteles, Marta ^a   Molina Medina, Araceli ^b   Bermejo Saiz, Elisa ^b   Ruiz Laiglesia, Fernando ^a   Nieto Rodriguez, José Antonio ^b   Pérez Calvo, Juan I ^a  

^a HOSPITAL CLÍNICO UNIVERSITARIO LOZANO BLESA   (Spain)

^b HOSPITAL VIRGEN DE LA LUZ   (Spain)

Author keywords

Brain natriuretic peptide; Chronic pulmonary disease; Heart failure; Mortality; NT proBNP; Prognosis

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; DIURETIC AGENT;

ADULT; AGED; ARTICLE; CHRONIC LUNG DISEASE; DISEASE EXACERBATION; FEMALE; FOLLOW UP; HOSPITAL READMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBSERVATIONAL STUDY; OXYGEN THERAPY; PROGNOSIS; PROSPECTIVE STUDY; SPAIN;

AGED; AGED, 80 AND OVER; BRONCHITIS, CHRONIC; FEMALE; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PROGNOSIS; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 77957120014     PISSN: 00257753     EISSN: 15788989     Source Type: Journal    
DOI: 10.1016/j.medcli.2009.11.047     Document Type: Article

References (19)

1. Grupo de Trabajo-conferencia de consenso sobre la EPOC Arch Bronconeumol 39 Supl. 3 2003 1 47
2. Zapatero-Gaviria A, Barba-Martn R. Altas atendidas en Medicina Interna en los Hospitales generales del Sistema Nacional de Salud, ao 2005. Sociedad Espaola de Medicina Interna. Grupo de Gestin Clnica de la Sociedad Espaola de Medicina Interna. Jarpyo ediciones, Madrid. 2008. p. 359.
3. W.M. Chatila, B.M. Thomashow, O.A. Minai, G.J. Criner, and B.J. Make Comorbidities in chronic obstructive Pulmonary disease Proc Am Thorac Soc 5 2008 549 555
4. A. Martinez-Rumayor, A.M. Richards, J.C. Burnett, and J.L. Januzzi Biology of the Natriuretic Peptides Am J Cardiol 101 suppl 2008 3A 8A
5. M. Nieminen, M. Bhm, M.R. Cowie, H. Drexler, G.S. Filippatos, and G. Jondeau Guas de Prctica Clnica sobre el diagnstico y tratamiento de la insuficiencia cardiaca aguda (Versin resumida) Rev Esp Cardiol 58 2005 389 429
6. P. Bettencourt, A. Azevedo, J. Pimento, F. Friones, S. Ferreira, and A. Ferreira N-terminal-pro-Brain natriuretic peptide predicts outcome after Hospital discharge in heart failure patients Circulation 110 2004 2168 2174
7. V. Cheng, R. Kazanagra, A. Garcia, L. Lenert, P. Krishnaswamy, and N. Gardetto A Rapid Bedside Test for B-Type Peptide Predicts Treatment Outcomes in Patients Admitted for Decompensated Heart Failure: A Pilot Study J Am Coll Cardiol 37 2001 286 291
8. P. Bettencourt, A. Azevedo, L. Fonseca, J.P. Arajo, S. Ferreira, and R. Almeida Prognosis of decompensate heart failure patients with preserved systolic function is predicted by NT-proBNP variations during hospitalization Int J Cardiol 117 2007 75 79
9. Baggish AL, van Kimmenade RRJ, Januzzi JL. The differential Diagnosis of an elevated amino-terminal pro-B-type natriuretic peptide level. Am J Cardiol 1008; 101 (suppl): 43A8A.
10. M.A. Burke, and W. Cotts Interpretation of B-type natriuretic peptide in cardiac disease and other comorbid conditions Heart Fail Rev 12 2007 23 36
11. C. Kragelund, B. Gronnig, L. Kober, P. Hildebrandt, and R. Steffnsen N-Terminal pro B-type natriuretic peptide and long term mortality in stable coronary heart disease N Engl J Med 352 2005 666 675 (Pubitemid 40239214)
12. Global initiative for Chronic Obstructive Lung Disease (GOLD) Executive and Science Committee. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease (Updated 2007). Disponible en: www.goldcopd.com.
13. Gua de prctica clnica de diagnstico y tratamiento de la Enfermedad Pulmonar Obstructiva Crnica. SEPAR-ALAT, 2007. Disponible en: www.separ.es.
14. F. Abroug, and L. Ouanes-besbes Detection of acute heart failure in chronic obstructive pulmonary disease: role of B-type natriuretic peptide Curr Opin Crit Care 14 2008 340 347
15. D. Stolz, T. Breidthardt, M. Christ-Crain, R. Bingisser, D. Miedinger, and J. Leuppi Use of B-Type Natriuretic Peptide in the risk stratification of acute exacerbations of COPD Chest 133 2008 1088 1094 (Pubitemid 351685510)
16. A. Bays-Genis NT-proBNP circulante, un nuevo biomarcador para el diagnstico del paciente con disnea aguda Rev Esp Cardiol 58 2005 1142 1144
17. B. Zvezdin, S. Milutinov, M. Kojicic, S. Hromis, M. Markovic, and O. Gajic A post-mortem analysis of major causes of early death in patients hospitalized with COPD exacerbation Chest 136 2009 376 380
18. D.E. Niewoehner The impact of severe exacerbations on quality of life and the clinical course of chronic obstructive pulmonary disease Am J Med 119 10 Suppl 1 2006 38 45
19. L.C. Boudestein, F.H. Rutten, M.J. Cramer, J.W. Lammers, and A.W. Hoes The impact of concurrent heart failure on prognosis in patients with chronic obstructive pulmonary disease Eur J Heart Fail 11 2009 1182 1188